• BRIMONIDINE TARTRATE CHEMBL2062257 FDA Approved

    Alternate Names:

    Brymont
    Brimonidine Tartrate
    AGN-190342-LF
    UK-1430418
    Alphagan
    Simbrinza
    Sandoz Brimonidine
    Ratio-brimonidine
    PMS-brimonidine
    Onreltea
    Mirvaso
    Jamp-brimonidine
    Dom-brimonidine
    Combigan
    Brimonidine Tartrate Ophthalmic Solution, 0.2%
    Brimonidine Tartrate Ophthalmic Solution 0.2%
    Brimonidine P
    Brimonidine Ophthalmic
    Brimonidine
    Apo-brimonidine-timop
    Apo-brimonidine
    Alphagan P
    59803-98-4
    Bromoxidine
    Brimonidinum
    Brimonidina
    DB00484
    S4266,70359-46-5
    MOLPORT-035-395-833
    72376318
    6-QUINOXALINAMINE, 5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-, (S-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1)
    6-QUINOXALINAMINE, 5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1)
    6-QUINOXALINAMINE, 5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
    109826-56-4
    (2R,3R)-2,3-DIHYDROXYBUTANEDIOIC ACID; 5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOXALIN-6-AMINE
    (5-BROMO-QUINOXALIN-6-YL)-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-AMINE L-TARTRATE
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE L-TARTRATE
    (4,5-BIHYDRO-1H-IMIDAZOL-2-YL)QUINOXALIN-6-AMINE L-TARTRATE
    BRIMONIDINE TARTRATE (1:1), (S-(R*,R*))-ISOMER
    3B2-5743
    D02076
    A19740
    W0014
    ST24046243
    LS-177484
    AB0021226
    DR002734
    AN-12800
    AK-68418
    L(+)-TARTARIC ACID; BRIMONIDINE
    CCG-221278
    AKOS016845265
    DNC000353
    EBD23481
    ACT08633
    59803-98-4 (PARENT)
    BRIMONIDINE TARTRATE [USAN:JAN]
    BRIMONIDINE TARTRATE (JAN/USAN)
    AGN 190342LF
    HY-B0659A
    SCHEMBL265607
    UK 14,304 (TARTRATE)
    BRIMONIDINE TARTRATE [USAN]
    4S9CL2DY2H
    AC1Q59OR
    AC1L1GYC
    BRIMONIDINE L-TARTRATE
    5-BROMO-N-
    BRIMONIDINNE TARTRATE
    BRIMONIDINE TARTARATE
    ALPHAGAN (TN)
    BRIMONIDINE PURITE
    79570-19-7
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOXALIN-6-AMINE; (2R,3R)-2,3-DIHYDROXYBUTANEDIOIC ACID
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOXALIN-6-AMINE (2R,3R)-2,3-DIHYDROXYSUCCINATE
    C11H10BRN5.C4H6O6
    UNII-4S9CL2DY2H
    BRIMONIDINE D-TARTRATE
    BROMINIDE TARTRATE
    70359-46-5
    BRIMONIDINE D-TARTARATE
    54405
    AGN 190342-LF
    MOLPORT-023-220-671
    59803-99-5
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE TATRATE
    5-BROMO-6-(2-IMIDAZOLIN-2-YLAMINO)QUINOXALINE TARTRATE
    I06-0561
    S-8158
    ST51052789
    TL8006987
    RT-001413
    BC004062
    VA10431
    LS40084
    AC-3599
    AKOS015895446
    MOLPORT-003-845-306
    CTK3J3327
    KSC493G2P
    UK14,304TARTRATE
    SCHEMBL34649
    PUBCHEM15967
    UK 14,304 TARTRATE
    11236066
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE TARTRATE
    KB-42499
    5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOXALIN-6-AMINE; (2S,3S)-2,3-DIHYDROXYBUTANEDIOIC ACID
    FT-0082637
    BC208828
    AK142929
    AKOS022175702
    SNJ-2022
    MOLPORT-016-638-379
    C15H16BRN5O6
    SCHEMBL34647
    AC1OCEPC
    ALPHAGAN Z
    AIPHAGAN P
    NOVADUR
    AIPHAGAN
    1400635-36-0
    6917831
    BRIMONIDINE L-TARTARATE

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories sympathomimetics in glaucoma therapy
    Drug Categories sensory organs
    Drug Categories quinoxalines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories ophthalmologicals
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories hypotensive agents
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories cardiovascular agents
    Drug Categories antihypertensive agents
    Drug Categories antiglaucoma preparations and miotics
    Drug Categories alpha2 agonists
    Drug Categories adrenergic alpha-agonists
    Drug Categories adrenergic alpha-2 receptor agonists
    Drug Categories adrenergic agonists
    Drug Categories adrenergic agents
    Drug Groups approved
    Drug Type small molecule
    (0 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Mechanism of Interaction Adrenergic receptor alpha-2 agonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Mechanism of Interaction Adrenergic receptor alpha-2 agonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Mechanism of Interaction Adrenergic receptor alpha-2 agonist
    Direct Interaction yes

    Publications: